Maler, Victor
Goetz, Violette
Tardieu, Marine
Khalil, Abderrahmane El
Alili, Jean Meidi
Meunier, Philippe
Maillot, François
Labarthe, François http://orcid.org/0000-0001-9788-9667
Article History
Received: 25 January 2023
Accepted: 4 June 2023
First Online: 8 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: FM reports consulting fees from Biomarin and PTC Therapeutics. FL reports advisory board participation for AlfaSigma and Sanofi Genzyme, and consulting fees from AlfaSigma, Biomarin and Sanofi Genzyme. The authors declare that they have no competing interests.